«Ventricular Dysfunction

Below is an extended Ventricular Dysfunction patents listing. Click here to return to the Ventricular Dysfunction main in depth entry.

Patents :
US Patent No.	Title
7371822	Human G-protein coupled receptor variant of HM74, HGPRBMY74
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7396829	Nitric oxide enhancing diuretic compounds, compositions and methods of use
7402312	Antibodies to vascular endothelial growth factor 2 (VEGF-2)
7402575	Methods of treating inflammation
7403823	Super plastic design for CHF pacemaker lead
7404793	Heart failure treatment device and method
7404802	Trending of systolic murmur intensity for monitoring cardiac disease with implantable device
7405234	Bicyclic modulators of androgen receptor function
7410461	Cardiac treatment apparatus
7410941	Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin
7393652	Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
7392094	Implantable lead for septal placement of pacing electrodes
7375133	Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
7378426	Fused heterotricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3
7381181	Device for treating heart failure
7381800	Antibodies to HBIMF63 polypeptide
7384917	Chimeric natriuretic peptides
7384976	Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use
7388027	Bicyclic compounds as modulators of androgen receptor function and method
7389141	Biatrial pacing optimization for biventricular pacing
7390637	Keratinocyte derived interferon
7392084	Demand-based cardiac function therapy
7410983	Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
7411051	Antibodies to HDPPA04 polypeptide
7417038	Methods of treating cachexia
7442687	2-polycyclic propynyl adenosine analogs having A2A agonist activity
7445605	Detection of apex motion for monitoring cardiac dysfunction
7445933	Stable calibrators or controls for measuring human natriuretic peptides
7446121	Pyrazole-based HMG CoA reductase inhibitors
7446176	12 human secreted proteins
7446185	Her2/neu target antigen and use of same to stimulate an immune response
7449292	Methods for predicting relative efficacy of a beta blocker therapy based on a B1-adrenergic receptor polymorphism
7450988	Method and apparatus for minimizing post-infarct ventricular remodeling
7452532	Transluminal application of adult stem cells for body organ tissue repair
7452538	Death domain containing receptor 4 antibodies and methods
7442397	PEGylated fibrinogen-based biomatrix
7442386	Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies
7417040	Fused tricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3
7419469	Method and system for diagnostigraphic based interactions in diagnostic medical imaging
7422558	Device for treating heart failure
7423032	Method for treating severe heart failure and medicament therefor
7425622	Antibodies against C3a receptor
7429646	Antibodies to human tumor necrosis factor receptor-like 2
7431914	Contrast agent
7432107	Cardiac hormones for assessing cardiovascular risk
7435213	Device for treating heart failure
7435808	Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2
7456256	BGS 4

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.